US Patent Issued to Incannex Healthcare on May 26 for "Compositions and methods for the treatment of obstructive sleep apnoea (OSA)" (Australian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,295, issued on May 26, was assigned to Incannex Healthcare Ltd. (Norwest, Australia).

"Compositions and methods for the treatment of obstructive sleep apnoea (OSA)" was invented by Mark Robert Bleackley (South Morang, Australia), Sudhanshu Agarwal (Toorak, Australia) and Joel Bradley Latham (North Kellyville, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions including triangle-9-tetrahydrocannabinol (THC) and a carbonic andydrase inhibitor and methods of using these compositions for the treatment of obstructive sleep apnoea (OSA). The treatment method also includes administering dronabinol and acetazolaminde and combinations there...